{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:16:01Z","timestamp":1777932961911,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Preeclampsia (PE) can occur antepartum or postpartum. When it develops de novo after childbirth, it is termed new-onset postpartum PE (NOPPE). Often, antepartum PE disappears after childbirth; however, in some women it persists after childbirth. This form of PE is termed persistent PE (PPE). Thus, there are two forms of postpartum PE: NOPPE and PPE. The pathogenesis and pathophysiology of these diseases have not been fully characterized, and whether NOPPE and PPE are different or similar pathological conditions remains unexplored. Thus, we aimed to compare the haematological and biochemical characteristics of NOPPE and PPE, predict the occurrence of new-onset PE and identify lifestyles that predispose women to postpartum PE. A total of 130 women comprising 65 normotensive postpartum women, 33 NOPPE and 32 PPE women were recruited for this hospital-based case\u2013control study. The socio-demographic and lifestyle characteristics of the participants were obtained through well-structured questionnaires. Haematological and biochemical indices were measured using automated analysers and ELISA. The prevalence of postpartum PE was 11.9%. Dyslipidaemia (p\u2009=\u2009\u2009&lt;\u20090.0001), hypomagnesaemia (p\u2009=\u2009\u2009&lt;\u20090.001), elevated serum levels of ALT, AST (p\u2009=\u2009\u2009&lt;\u20090.0001), sVCAM-1 (p\u2009=\u2009\u2009&lt;\u20090.0001) and sFlt-1 (p\u2009=\u2009\u2009&lt;\u20090.0001) were more prevalent and severe in the PPE than in the NOPPE. Sedentary lifestyle was common among both groups of hypertensive women. Elevated ALT and AST were significant predictors of NOPPE. These findings indicate that preeclampsia exists after childbirth in a high percentage of women. NOPPE and PPE are different pathological conditions that require different clinical management. Combined glucose, lipid and liver assessment could be useful in predicting postpartum PE.<\/jats:p>","DOI":"10.1038\/s41598-022-07509-5","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:37:47Z","timestamp":1646383067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hematobiochemical variability and predictors of new-onset and persistent postpartum preeclampsia"],"prefix":"10.1038","volume":"12","author":[{"given":"Linda Ahenkorah","family":"Fondjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Amoah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Jude","family":"Annan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoch Appiah","family":"Adu-Gyamfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans Adu","family":"Asamaoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"7509_CR1","first-page":"134","volume":"2","author":"AC Staff","year":"2019","unstructured":"Staff, A. C. The two-stage placental model of preeclampsia: An update. J. Reprod. Immunol. 2, 134\u2013135 (2019).","journal-title":"J. Reprod. Immunol."},{"key":"7509_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fphys.2018.00973","volume":"9","author":"Z Armaly","year":"2018","unstructured":"Armaly, Z., Jadaon, J. E., Jabbour, A. & Abassi, Z. A. Preeclampsia: Novel mechanisms and potential therapeutic approaches. Front. Physiol. 9, 2 (2018).","journal-title":"Front. Physiol."},{"key":"7509_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.aoa.0000429108.28877.2d","volume":"33","author":"BM Sibai","year":"2013","unstructured":"Sibai, B. M. Etiology and management of postpartum hypertension-preeclampsia. Obstet. Anesth. Dig. 33, 77\u201378 (2013).","journal-title":"Obstet. Anesth. Dig."},{"key":"7509_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5468\/ogs.2016.59.6.434","volume":"59","author":"G Vilchez","year":"2016","unstructured":"Vilchez, G., Hoyos, L. R., Leon-Peters, J., Lagos, M. & Argoti, P. Differences in clinical presentation and pregnancy outcomes in antepartum preeclampsia and new-onset postpartum preeclampsia: Are these the same disorder?. Obstetr. Gynecol. Sci. 59, 434\u2013443 (2016).","journal-title":"Obstetr. Gynecol. Sci."},{"key":"7509_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/AOG.0b013e318231934c","volume":"118","author":"Z Al-Safi","year":"2011","unstructured":"Al-Safi, Z. et al. Delayed postpartum preeclampsia and eclampsia: Demographics, clinical course, and complications. Obstetr. Gynecol. 118, 2 (2011).","journal-title":"Obstetr. Gynecol."},{"key":"7509_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2167-0420.1000375","volume":"6","author":"H Zamane","year":"2017","unstructured":"Zamane, H. et al. Postpartum arterial hypertension in African setting Ouagadougou. J. Womens Health Care 6, 2 (2017).","journal-title":"J. Womens Health Care"},{"key":"7509_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12884-015-0624-y","volume":"15","author":"CA Turpin","year":"2015","unstructured":"Turpin, C. A., Sakyi, S. A., Owiredu, W. K. B. A., Ephraim, R. K. D. & Anto, E. O. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnan. Childbirth 15, 2 (2015).","journal-title":"BMC Pregnan. Childbirth"},{"key":"7509_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1155\/2020\/3251956","volume":"2020","author":"W Tashie","year":"2020","unstructured":"Tashie, W. et al. Altered bioavailability of nitric oxide and L-arginine is a key determinant of endothelial dysfunction in preeclampsia. BioMed Res. Int. 2020, 2 (2020).","journal-title":"BioMed Res. Int."},{"key":"7509_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/cbf.3458","volume":"38","author":"EA Adu-Gyamfi","year":"2020","unstructured":"Adu-Gyamfi, E. A. et al. The role of adiponectin in placentation and preeclampsia. Cell Biochem. Funct. 38, 2 (2020).","journal-title":"Cell Biochem. Funct."},{"key":"7509_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler, H. et al. Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374, 13\u201322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"7509_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","volume":"69","author":"U Sovio","year":"2017","unstructured":"Sovio, U. et al. Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: A prospective cohort study of unselected nulliparous women. Hypertension 69, 731\u2013738 (2017).","journal-title":"Hypertension"},{"key":"7509_CR12","first-page":"2","volume":"2","author":"P Lafuente-Ganuza","year":"2019","unstructured":"Lafuente-Ganuza, P. et al. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1\/PlGF ratio and NT-proBNP as biomarkers. Clin. Chem. Lab. Med. 2, 2 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"key":"7509_CR13","first-page":"2","volume":"17","author":"Y Veisani","year":"2019","unstructured":"Veisani, Y., Jenabi, E., Delpisheh, A. & Khazaei, S. Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis. Int. J. Reprod. BioMed. 17, 2 (2019).","journal-title":"Int. J. Reprod. BioMed."},{"key":"7509_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajog.2011.09.002","volume":"206","author":"BM Sibai","year":"2012","unstructured":"Sibai, B. M. Etiology and management of postpartum hypertension-preeclampsia. Am. J. Obstetr. Gynecol. 206, 2 (2012).","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"7509_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"TG Pickering","year":"2005","unstructured":"Pickering, T. G. et al. Recommendations for blood pressure measurement in humans and experimental animals. Circulation 111, 2 (2005).","journal-title":"Circulation"},{"key":"7509_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12884-019-2623-x","volume":"19","author":"LA Fondjo","year":"2019","unstructured":"Fondjo, L. A., Boamah, V. E., Fierti, A., Gyesi, D. & Owiredu, E. W. Knowledge of preeclampsia and its associated factors among pregnant women: A possible link to reduce related adverse outcomes. BMC Pregnan. Childbirth 19, 2 (2019).","journal-title":"BMC Pregnan. Childbirth"},{"key":"7509_CR17","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/bjsports-2018-099836","volume":"52","author":"MH Davenport","year":"2018","unstructured":"Davenport, M. H. et al. Impact of prenatal exercise on neonatal and childhood outcomes: A systematic review and meta-analysis. Br. J. Sports Med. 52, 1386\u20131396 (2018).","journal-title":"Br. J. Sports Med."},{"key":"7509_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen, B. K. & Febbraio, M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457\u2013465 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"7509_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3923\/jms.2008.443.451","volume":"8","author":"CA Turpin","year":"2008","unstructured":"Turpin, C. A., Ahenkorah, L., Owiredu, W., Laing, E. F. & Amidu, N. The prevalence of the metabolic syndrome among Ghanaian pregnancy induced hypertensive patients using the World health Organisation and the national Cholesterol Education Program III criteria. J. Med. Sci. 8, 443\u2013451 (2008).","journal-title":"J. Med. Sci."},{"key":"7509_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/jcm8101625","volume":"8","author":"R Fox","year":"2019","unstructured":"Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L. & Lewandowski, A. J. Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J. Clin. Med. 8, 1625 (2019).","journal-title":"J. Clin. Med."},{"key":"7509_CR21","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3390\/ijms19113608","volume":"19","author":"AC Improta Caria","year":"2018","unstructured":"Improta Caria, A. C. et al. Exercise training-induced changes in MicroRNAs: Beneficial regulatory effects in hypertension, type 2 diabetes, and obesity. Int. J. Mol. Sci. 19, 3608 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"7509_CR22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1440-1681.2008.05031.x","volume":"35","author":"B Paul","year":"2008","unstructured":"Paul, B., Wilfred, N. C., Woodman, R. & DePasquale, C. Prevalence and correlates of anaemia in essential hypertension. Clin. Exp. Pharmacol. Physiol. 35, 1461\u20131464 (2008).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"7509_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2369-14-24","volume":"14","author":"O Dmitrieva","year":"2013","unstructured":"Dmitrieva, O. et al. Association of anaemia in primary care patients with chronic kidney disease: Cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol. 14, 24 (2013).","journal-title":"BMC Nephrol."},{"key":"7509_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrneph.2015.82","volume":"11","author":"MJ Koury","year":"2015","unstructured":"Koury, M. J. & Haase, V. H. Anaemia in kidney disease: Harnessing hypoxia responses for therapy. Nat. Rev. Nephrol. 11, 394\u2013410 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"7509_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss, G., Ganz, T. & Goodnough, L. T. Anemia of inflammation. Blood 133, 40\u201350 (2019).","journal-title":"Blood"},{"key":"7509_CR26","first-page":"100638","volume":"2","author":"AM Pishko","year":"2019","unstructured":"Pishko, A. M., Levine, L. D. & Cines, D. B. Thrombocytopenia in pregnancy: Diagnosis and approach to management. Blood Rev. 2, 100638 (2019).","journal-title":"Blood Rev."},{"key":"7509_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5005\/jp-journals-10071-23277","volume":"23","author":"M Harde","year":"2019","unstructured":"Harde, M., Bhadade, R., deSouza, R. & Jhingan, M. Thrombocytopenia in pregnancy nearing term: A clinical analysis. Indian J. Crit. Care Med. 23, 503 (2019).","journal-title":"Indian J. Crit. Care Med."},{"key":"7509_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0895-7061(02)02964-3","volume":"15","author":"SH Jee","year":"2002","unstructured":"Jee, S. H. et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials*. Am. J. Hypertens. 15, 691\u2013696 (2002).","journal-title":"Am. J. Hypertens."},{"key":"7509_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","volume":"67","author":"SA Karumanchi","year":"2016","unstructured":"Karumanchi, S. A. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension 67, 1072\u20131079 (2016).","journal-title":"Hypertension"},{"key":"7509_CR30","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1172\/JCI76864","volume":"124","author":"X Fan","year":"2014","unstructured":"Fan, X. et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J. Clin. Investig. 124, 4941\u20134952 (2014).","journal-title":"J. Clin. Investig."},{"key":"7509_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134\u2013135","author":"AC Staff","year":"2019","unstructured":"Staff, A. C. The two-stage placental model of preeclampsia: An update. J. Reprod. Immunol. 134\u2013135, 1\u201310 (2019).","journal-title":"J. Reprod. Immunol."},{"key":"7509_CR32","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.3390\/ijms160612436","volume":"16","author":"CA Souders","year":"2015","unstructured":"Souders, C. A. et al. Circulating levels of sFlt1 splice variants as predictive markers for the development of preeclampsia. Int. J. Mol. Sci. 16, 12436\u201312453 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"7509_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pone.0124684","volume":"10","author":"Z Bian","year":"2015","unstructured":"Bian, Z., Shixia, C. & Duan, T. First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia. PLoS ONE 10, 2 (2015).","journal-title":"PLoS ONE"},{"key":"7509_CR34","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nat. Biotechnol. 36, 1164\u20131173 (2018).","journal-title":"Nat. Biotechnol."},{"key":"7509_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jri.2015.07.004","volume":"114","author":"DS Charnock-Jones","year":"2016","unstructured":"Charnock-Jones, D. S. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia. J. Reprod. Immunol. 114, 81\u201385 (2016).","journal-title":"J. Reprod. Immunol."},{"key":"7509_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine, R. J. et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992\u20131005 (2006).","journal-title":"N. Engl. J. Med."},{"key":"7509_CR37","first-page":"69","volume":"23","author":"KR Palmer","year":"2017","unstructured":"Palmer, K. R., Tong, S. & Kaitu\u2019u-Lino, T.J.,. Placental-specific sFLT-1: Role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis. Mhr Basic sci. Reprod. Med. 23, 69\u201378 (2017).","journal-title":"Mhr Basic sci. Reprod. Med."},{"key":"7509_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Investig. 111, 649\u2013658 (2003).","journal-title":"J. Clin. Investig."},{"key":"7509_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14767050500202493","volume":"18","author":"E Bujold","year":"2005","unstructured":"Bujold, E. et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J. Matern. Fetal Neonatal Med. 18, 9\u201316 (2005).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"7509_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17547","volume":"51","author":"L Saleh","year":"2018","unstructured":"Saleh, L. et al. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia. Ultrasound Obstet. Gynecol. 51, 751\u2013757 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"7509_CR41","first-page":"689","volume":"16","author":"M Farzadnia","year":"2013","unstructured":"Farzadnia, M., Ayatollahi, H., Hasan-zade, M. & Rahimi, H. R. A comparative study of serum level of vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (ICAM-1) and high sensitive C-reactive protein (hs-CRP) in normal and pre-eclamptic pregnancies. Iran. J. Basic Med. Sci. 16, 689 (2013).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"7509_CR42","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1053\/euhj.2002.3188","volume":"23","author":"NT Mulvihill","year":"2002","unstructured":"Mulvihill, N. T., Foley, B., Crean, P. & Walsh, M. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur. Heart J. 23, 1569\u20131574 (2002).","journal-title":"Eur. Heart J."},{"key":"7509_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2005.12.030","volume":"368","author":"J Constans","year":"2006","unstructured":"Constans, J. & Conri, C. Circulating markers of endothelial function in cardiovascular disease. Clin. Chim. Acta 368, 33\u201347 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"7509_CR44","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina, E. & Ley, K. Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2292\u20132301 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"7509_CR45","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1161\/01.ATV.17.11.2646","volume":"17","author":"R De Caterina","year":"1997","unstructured":"De Caterina, R. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17, 2646\u20132654 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"7509_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","volume":"18","author":"J Hurtubise","year":"2016","unstructured":"Hurtubise, J. et al. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr. Atheroscler. Rep. 18, 82 (2016).","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07509-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07509-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07509-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T06:42:22Z","timestamp":1700289742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07509-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7509"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07509-5","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/K2Y5SO","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3583"}}